androstane-3,17-diol has been researched along with Glioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dent, P; Graf, MR; Jia, W; Johnson, RS; Loria, RM; Mitchell, C | 1 |
| Graf, MR; Jia, W; Loria, RM | 1 |
2 other study(ies) available for androstane-3,17-diol and Glioma
| Article | Year |
|---|---|
Autophagy and the functional roles of Atg5 and beclin-1 in the anti-tumor effects of 3beta androstene 17alpha diol neuro-steroid on malignant glioma cells.
Topics: Anabolic Agents; Androstane-3,17-diol; Animals; Apoptosis Regulatory Proteins; Autophagy; Autophagy-Related Protein 5; Beclin-1; Cell Line, Tumor; Glioma; Humans; Membrane Proteins; Mice; Microtubule-Associated Proteins; Organelles; Protein Kinases; Proto-Oncogene Proteins c-akt; Rats; RNA, Small Interfering; Signal Transduction; TOR Serine-Threonine Kinases | 2009 |
The neuro-steroid, 3beta androstene 17alpha diol exhibits potent cytotoxic effects on human malignant glioma and lymphoma cells through different programmed cell death pathways.
Topics: Androstane-3,17-diol; Apoptosis; Blotting, Western; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Fragmentation; Dose-Response Relationship, Drug; Flow Cytometry; Glioma; Humans; In Situ Nick-End Labeling; Lymphoma; Molecular Structure; Phagosomes; Poly(ADP-ribose) Polymerases; Signal Transduction; U937 Cells | 2007 |